Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 50023493
TargetRibosomal protein S6 kinase alpha-5(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269815(25-hydroxy-13(24),15,17-cheilanthatrien-19,25-olid...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of MSK1 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-5(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269822(16,25-dihydroxy-13(24),17-cheilanthadien-19,25-oli...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of MSK1 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-5(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269821(25-hydroxy-13(24),17-cheilanthadien-16,19-olide | ...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of MSK1 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-5(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269820(13,16-epoxy-25-hydroxy-17-cheilanthen-19,25-olide ...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of MSK1 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269815(25-hydroxy-13(24),15,17-cheilanthatrien-19,25-olid...)
Affinity DataIC50: 9.00E+4nMAssay Description:Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269822(16,25-dihydroxy-13(24),17-cheilanthadien-19,25-oli...)
Affinity DataIC50: 9.00E+4nMAssay Description:Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269821(25-hydroxy-13(24),17-cheilanthadien-16,19-olide | ...)
Affinity DataIC50: 9.00E+4nMAssay Description:Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Astrazeneca R&D Griffith University

Curated by ChEMBL
LigandPNGBDBM50269820(13,16-epoxy-25-hydroxy-17-cheilanthen-19,25-olide ...)
Affinity DataIC50: 9.00E+4nMAssay Description:Inhibition of MAPKAPK2 assessed as [33P] incorporation by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed